These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1936509)
1. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study. Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests. Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226 [TBL] [Abstract][Full Text] [Related]
3. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial]. Rossini A; Tascino C; Costa F Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet treatment after carotid endarterectomy: a pilot study. Rodríguez y Baena R; Gaetani P; Bono G; Lavezzari M; Milanesi G J Neurosurg Sci; 1992; 36(1):39-45. PubMed ID: 1500957 [TBL] [Abstract][Full Text] [Related]
5. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen]. Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658 [TBL] [Abstract][Full Text] [Related]
6. Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group. Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):439-46. PubMed ID: 3899952 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication. Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316 [TBL] [Abstract][Full Text] [Related]
8. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation. Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227 [TBL] [Abstract][Full Text] [Related]
9. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study. Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003 [TBL] [Abstract][Full Text] [Related]
10. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
11. Indobufen: an updated review of its use in the management of atherothrombosis. Bhana N; McClellan KJ Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445 [TBL] [Abstract][Full Text] [Related]
12. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease]. Liusov VA; Diukov IV; Uteshev DV Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785 [No Abstract] [Full Text] [Related]
13. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients. Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671 [TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine. Carrieri PB; Orefice G; Sorge F Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach. Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432 [TBL] [Abstract][Full Text] [Related]
16. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis]. Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347 [TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets. Dmoszyńska A; Walter-Croneck A; Ledwozyw A Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274 [TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of indobufen in peripheral vascular disease. Belcaro G; De Simone P Angiology; 1991 Jan; 42(1):8-14. PubMed ID: 1992862 [TBL] [Abstract][Full Text] [Related]